Major Review Finds ‘Weak Evidence’ Supporting Puberty Blockers for Kids

There is “weak evidence” to support puberty blockers for children who identify as transgender, according to a four-year systematic review of transgender medical studies published on Tuesday.

Dr. Hilary Cass, a consultant in paediatric disability at St. Thomas’ Hospital in London, England, and formerly the president of the Royal College of Pediatrics and Child Health, conducted the review in response to a request from the National Health Service (NHS). Cass’ report determined that the current studies on the subject of “puberty suppression” showed little improvement in gender dysphoria in minors and also may push kids toward getting more extreme treatments.

Read More

‘Constitutional Crisis:’ Maine Bill Nationalizes Transgender Hormones as the U.K. Halts Them for Kids

Child at doctor's visit

Conservative elected officials sometimes accuse California of making policy choices for all Americans by dint of its population size and concomitant regulatory power.

Now they are threatening legal action against a Golden State mini-me for legislation that would purportedly override other states’ laws restricting abortion as well as puberty blockers, cross-sex hormones and genital surgeries for gender confusion.

Read More

England Bans the Use of Puberty Blockers at Nation’s Gender Identity Clinics

Doctor Patient

England’s National Health Service (NHS) has banned the use of puberty blockers to treat children with gender dysphoria at the nation’s gender identity clinics, Sky News reported.

Taking a position at odds with the Biden administration, Health Minister Maria Caulfield said: “We have always been clear that children’s safety and wellbeing is paramount, so we welcome this landmark decision by the NHS. Ending the routine prescription of puberty blockers will help ensure that care is based on evidence, expert clinical opinion and is in the best interests of the child.”

Read More

Commentary: More Gender Activists than Medical Professionals on WHO Transgender Health Panel

Last month, the World Health Organization (WHO) announced that it had formed a Guideline Development Group made up of 21 members tasked with writing WHO guidelines on “the health of trans and gender diverse people.”

As a specialized agency of the United Nations responsible for international public health, WHO is looked to by most of the world’s nations for leadership on public health policy. Of the world’s 195 countries, 194 are WHO member states, with Taiwan being the lone exception.

Read More